Abstract
Collagen VI is a ubiquitous extracellular matrix component that forms extensive microfibrillar networks in most connective tissues. In this study, we describe for the first time, to our knowledge, that the collagen VI von Willebrand factor type A–like domains exhibit a broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria in human skin infections in vivo. In silico sequence and structural analysis of VWA domains revealed that they contain cationic and amphipathic peptide sequence motifs, which might explain the antimicrobial nature of collagen VI. In vitro and in vivo studies show that these peptides exhibited significant antibacterial activity against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa through membrane disruption. Our findings shed new light on the role of collagen VI–derived peptides in innate host defense and provide templates for development of peptide-based antibacterial therapies.
Footnotes
This work was supported by the Swedish Foundation for Strategic Research (Grant SB12-0019), Lennanders Stiftelse, the Swedish Research Council (Project 7480), the Crafoord Foundation, the Johan and Greta Kock Foundation, the Alfred Österlund Foundation, the King Gustav V Memorial Fund Foundation, the Royal Physiographic Society of Lund, the Medical Faculty at Lund University, and Deutsche Forschungsgemeinschaft (SFB829).
The online version of this article contains supplemental material.
- Received April 26, 2017.
- Accepted June 1, 2018.
- Copyright © 2018 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.